Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“MedCity is invaluable among the many sources of industry reporting because the team endeavor to bring the truly new, and innovative opportunities and developments to light.”

Ken Kirby, President, Transdermal Delivery Solutions Corp


Sign up for our daily newsletter


State of biotech industry… Boom or bust? — MedCity morning read, May 18, 2009

9:10 am by | 2 Comments

Updated 8:55 p.m.

University of Texas researchComplete this statement: The U.S. biotechnology industry is…

  1. Battling the blues
  2. Stumbling
  3. Resilient
  4. Booming

All of these answers are correct and depend on where you’re sitting, in terms of geography and sector, according to four separate Business Journal stories.

Times are tough for biotech companies, says the Denver Business Journal. Funding is hard to find. And many drug developers are expected to fail in coming months, largely because of the nation’s economic recession, experts say.

The impact of the recession is being aggravated by a perception that it’s tougher, these days, to get a drug through the Food and Drug Administration approval process, Jim Linfield of Cooley, Godward & Kronish LLP. Then there are questions about how health care reform could affect the industry’s economics, Linfield says.

Georgia’s life sciences industry is stumbling because of a dearth of corporate success stories, according to the Atlanta Business Chronicle. Yet the U.S. industry is expected to outpace its European cousin, Financial Times says, writing from Atlanta where the Biotechnology Industry Organization begins its international convention today. 

But according to an opinion piece in the Atlanta Business Chronicle co-authored by Jim Greenwood — CEO of the national biotechnology trade organization — life sciences companies are resilient in the face of the challenging economy.

The future of the biotech industry is bright, in part, because many Americans rate finding cures for diseases as a top national priority, Greenwood writes.

Growth of biomedical business, research and development in Northeast Ohio grew faster than the national average in each of the last five years.

The industry is booming in the Golden Triangle of research facilities and biotech companies in San Diego, according to the Orlando Business Journal. Orlando’s Lake Nona community on Friday opened an $85 million satellite of San Diego’s Burnham Institute for Medical Research, where the local bio group says the region’s life science cluster has gone from “dreams to reality.”

And in Texas, the life sciences industry has had a $75 million economic impact on the state economy, according to the San Antonio Business Journal.

Boom or bust? You decide.

More stories worth a read:

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Mary Vanac

By Mary Vanac

Mary Vanac is a co-founder of MedCity News.
More posts by Author

2 comments
Alexis
Alexis

Hello, Mary. I'm a big fan of MedCity News - I tell everyone I can to subscribe! I'm curious why you didn't mention the recent report from ClevelandPlus/Team NEO on how Northeast Ohio is outpacing other geographic areas in the bio sector?

Mary Vanac
Mary Vanac

Alexis: Thanks for the comment, and thanks for reading!! The "morning read" is largely a collection of the previous day's news that's published by others. I wrote about the Team NEO biomedical report in April, but I added a link to that story in today's morning read because you asked for it :) Keep the tips coming! Mary Vanac